Showing results (1571-1580 of 1,868) with videos related to
Sort By:
Pageof 187
The Journal of Clinical Investigation|November 21, 2018
Peptide-based PET quantifies target engagement of PD-L1 therapeuticsDhiraj Kumar, Ala Lisok, Elyes Dahmane, et al.Cell Reports|June 1, 2022
Sustained Trem2 stabilization accelerates microglia heterogeneity and Aβ pathology in a mouse model of Alzheimer's diseaseRahul Dhandapani, Marilisa Neri, Mario Bernhard, et al.Frontiers in Pharmacology|June 16, 2023
Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivorsLukas Fiedler, Lukas J Motloch, Anna-Maria Dieplinger, et al.Infection Control and Hospital Epidemiology|September 6, 2017
Failure to Communicate: Transmission of Extensively Drug-Resistant bla OXA-237-Containing Acinetobacter baumannii-Multiple Facilities in Oregon, 2012-2014Genevieve L Buser, P Maureen Cassidy, Margaret C Cunningham, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2024
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung CancerDavid R Spigel, Afshin Dowlati, Yuanbin Chen, et al.ACR Open Rheumatology|November 4, 2024
Circulating Adipokines and Response to Treatment in Patients With Early Rheumatoid ArthritisGeorgios K Vasileiadis, Yuan Zhang, Tahzeeb Fatima, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2013
Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumorsAntonio Jimeno, Glen J Weiss, Wilson H Miller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2024
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung CancerNoura J Choudhury, W Victoria Lai, Alex Makhnin, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2019
Acquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung CancersMorana Vojnic, Daisuke Kubota, Christopher Kurzatkowski, et al.Science Advances|April 10, 2024
Molecular phenotyping of small cell lung cancer using targeted cfDNA profiling of transcriptional regulatory regionsJoseph B Hiatt, Anna-Lisa Doebley, Henry U Arnold, et al.Pageof 187